On the afternoon of March 12, TreeENT invited Professor Jiang Weihong, one of the pioneers of endoscopic skull base surgery in China, Professor Sun Guangbin from Huashan Hospital Affiliated to Fudan University, Professor Wang Dehui from the Eye & ENT Hospital of Fudan University, Director Hou Dongming from Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and other renowned ENT experts in Shanghai to discuss the minimally invasive neural blockade surgery for allergic rhinitis with Professor Shen Wei, Medical Director of TreeENT Healthcare Group, and doctors from TreeENT Eye & ENT hospitals.
Professor Jiang Weihong currently serves as Deputy Director of the Department of Otorhinolaryngology Head and Neck Surgery at Xiangya Hospital of Central South University, Director of the Skull Base Surgery Center, and Editorial Board Member and Editor-in-Chief of the Chinese Journal of Otorhinolaryngology and Skull Base Surgery. As one of the pioneers of endoscopic skull base surgery in China, he has long been dedicated to clinical and basic research in head and neck tumors, skull base surgery, and endoscopic nasal surgery. His work in the surgical treatment of skull base lesions has achieved leading domestic status, contributing significantly to advancing China's endoscopic skull base surgery standards.
Innovating Together: Exploring New Approaches to Allergic Rhinitis Treatment
During the seminar, Professor Jiang Weihong shared his extensive clinical experience through a systematic and detailed presentation on "Highly Selective Vidian Neurectomy for Allergic Rhinitis (AR)." He covered the theoretical basis, anatomical foundations, surgical objectives, methodologies, and the advantages and disadvantages of AR surgery. Drawing from past surgical cases, he elaborated on perioperative patient management as well as intraoperative and postoperative considerations. Additionally, he engaged in in-depth discussions with attending experts on the efficacy of various AR treatment modalities currently in use, including pharmacotherapy, desensitization therapy, and minimally invasive surgical interventions.
Professor Jiang Weihong acknowledged TreeENT's remarkable achievements in ENT specialty development, noting its leading position in standardized management and medical quality/safety among private healthcare institutions in China. He recognized TreeENT's success in transforming specialty features into competitive advantages, playing a pioneering role in driving industry development while exploring integration and enhancement of technical services between private and public hospitals.
Ms. Xu Jinghuan, founder of TreeENT, expressed gratitude for Professor Jiang's recognition and shared her perspectives on specialty medical development along with TreeENT's philosophy. She demonstrated TreeENT's commitment to professional and chain-based development, with confidence and determination to meet public demand through high-quality medical services.
Putting Ideas into Practice: The "TreeENT Model" of Delivering Premium Niche Specialty Care
During the exchange visit, accompanied by TreeENT Shanghai's management team, Professor Jiang toured various facilities including the outpatient lobby, ENT waiting area, clinical zones, and surgical center, while providing valuable suggestions for disciplinary development. Professor Jiang praised TreeENT's core values of "safe, efficient, and compassionate" healthcare, particularly commending the advanced hardware facilities, renowned expert team, patient-centered services, and high-quality talent pool.
As a leading private high-end ENT specialty medical institution in China, Renshu Medical consistently adheres to the "patient-centered" service philosophy. By introducing international premium healthcare systems and leveraging advantages in top-tier medical expertise and internationally certified quality management, Renshu has developed its distinctive model combining "ENT specialty centers with international minimally invasive surgery centers," meeting patients' growing demand for high-quality niche specialty care.
The academic exchange on "Minimally Invasive Neurectomy for Allergic Rhinitis" has significantly contributed to enhancing Renshu Medical's specialized treatment capabilities and patient service standards, while providing valuable academic insights to advance ENT specialty diagnostics and treatment technologies in China.
Moving forward, Renshu Medical will continue to focus on cutting-edge diagnostic and treatment technologies and the latest academic research achievements globally. Through strengthened collaboration and knowledge exchange with industry experts, Renshu is committed to promoting more scientific and specialized development in China's niche specialty research and new technology applications, contributing its expertise to realize precision medicine and deliver premium healthcare services.
